United States — Total revenues
Incyte United States — Total revenues decreased by 17.8% to $1.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $981.56M to $1.17B. Over 4 years (FY 2021 to FY 2025), United States — Total revenues shows an upward trend with a 13.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product adoption, effective pricing strategies, or expansion of the patient base within the U.S. market. A decrease may signal increased competition, patent expirations, or regulatory pricing pressures.
Detailed definition
This metric represents the total gross revenue generated from all commercial activities within the United States geograp...
Peer comparison
Comparable to domestic revenue segments reported by other large-cap biopharmaceutical companies, typically benchmarked against regional market growth rates.
incy_segment_united_states_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $725.00M | $725.00M | $725.00M | $800.00M | $800.00M | $800.00M | $800.00M | $878.72M | $878.72M | $878.72M | $878.72M | $828.20M | $989.03M | $1.07B | $1.09B | $981.56M | $1.13B | $1.26B | $1.42B | $1.17B |
| QoQ Change | — | +0.0% | +0.0% | +10.3% | +0.0% | +0.0% | +0.0% | +9.8% | +0.0% | +0.0% | +0.0% | -5.7% | +19.4% | +8.2% | +1.6% | -9.7% | +15.4% | +11.4% | +13.0% | -17.8% |
| YoY Change | — | — | — | — | +10.3% | +10.3% | +10.3% | +9.8% | +9.8% | +9.8% | +9.8% | -5.7% | +12.6% | +21.8% | +23.7% | +18.5% | +14.5% | +17.9% | +31.0% | +19.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's united states — total revenues?
- Incyte (INCY) reported united states — total revenues of $1.17B in Q1 2026.
- How has Incyte's united states — total revenues changed year-over-year?
- Incyte's united states — total revenues increased by 19.3% year-over-year, from $981.56M to $1.17B.
- What is the long-term trend for Incyte's united states — total revenues?
- Over 4 years (2021 to 2025), Incyte's united states — total revenues has grown at a 13.4% compound annual growth rate (CAGR), from $2.90B to $4.80B.
- What does united states — total revenues mean?
- The total amount of money earned from business activities conducted in the United States.